I could reverse it, if that's helpful to answer.
There certainly are examples where we don't have access to tools--and we call these tools in our tool box--where we're disadvantaged in relation to our competition.
The other situation that has to be addressed, and addressed immediately, particularly when we're in crises, is that it's the opposite to human drugs, as I understand it. Human medicine products are less expensive in Canada than in the U.S. On the livestock side, it's just the reverse.
So we're currently looking at what they've done in PMRA. We have a cross-commodity group taking a look at it, trying to figure out what we could do, what we could promote. The veterinary drugs directorate has said, for ten years already, we're going to get better, we can make adjustments--but, ladies and gentlemen, it's not happening fast enough.